CONCLUSIONS: Dialysis patients with HUS were at significantly higher risk than matched control patients for hospitalizations due to cardiovascular, hematologic, and pancreatic disease, which were associated with ongoing TMA. Additional studies are needed to determine whether targeted therapy for HUS reduces hospitalizations.
PMID: 25491936 [PubMed - as supplied by publisher] (Source: Journal of Nephrology)